Discontinuation report REPRONEX

Last updated on 2019-04-27 History
Report ID 82569
Drug Identification Number 02247790
Brand name REPRONEX
Common or Proper name Menotropins for Injection
Company Name FERRING INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) MENOTROPINS
Strength(s) 75UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR SUBCUTANEOUS
Packaging size Boxes 5 vials + 5x2 mL vials diluent
ATC code G03GA
ATC description GONADOTROPHINS AND OTHER OVULATION STIMULANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-04-23
Remaining supply date 2019-04-23
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments REPRONEX is discontinued. Alternate products are available by Ferring such as MENOPUR (Menotropins for injection) (75 IU FSH/ 75 IU LH). Please contact your healthcare professional.
Health Canada comments
Tier 3 Status No
Contact Address 200 YORKLAND BLVD
TORONTO, ONTARIO
CANADA M2J 5C1
Company contact information 1-800-263-4057

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-04-27 French Compare
v6 2019-04-27 English Compare
v5 2019-04-27 English Compare
v4 2019-04-26 French Compare
v3 2019-04-26 English Compare
v2 2019-04-26 French Compare
v1 2019-04-26 English Compare

Showing 1 to 7 of 7